Refractory Tumorous and Neurodegenerative Histiocytosis Treated With Intra-Arterial Chemotherapy

This study provides Class IV evidence that in patients with tumorous or neurodegenerative histiocytosis, selective angiographic catheterization and intra-arterial infusion of melphalan result in radiologic and functional improvement.

Authors

Institutions

Publication Details

Journal
Neurology Neuroimmunology & Neuroinflammation
Published
2025-10-23
DOI
https://doi.org/10.1212/nxi.0000000000200495
Citations
1
Primary Topic
Histiocytic Disorders and Treatments
Type
article
Field-Weighted Citation Impact
1.16
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Refractory Tumorous and Neurodegenerative Histiocytosis Treated With Intra-Arterial Chemotherapy

Mario E. Lacouture, Dana Bossert, Andrew Garton, Y. Pierre Gobin et al.
1 citations
Neurology Neuroimmunology & Neuroinflammation
Histiocytic Disorders and Treatments
1.16
article

Refractory Tumorous and Neurodegenerative Histiocytosis Treated With Intra-Arterial Chemotherapy

Mario E. Lacouture, Dana Bossert, Andrew Garton, Y. Pierre Gobin, Omar Abdel‐Wahab, Jesuel Padro‐Guzman, Alexander Ramos, Vaios Hatzoglou, Anne S. Reiner, David H. Abramson, Sonia Mahajan, Franchesca König, Julia M. Reilly, Ruham Alshiekh Nasany, Eli L. Diamond, Veronica Rotemberg, Jared Knopman, Jasmine H. Francis
article en
1 citations

Abstract

This study provides Class IV evidence that in patients with tumorous or neurodegenerative histiocytosis, selective angiographic catheterization and intra-arterial infusion of melphalan result in radiologic and functional improvement.

Neurology Neuroimmunology & NeuroinflammationVol. 12(6)
Memorial Sloan Kettering Cancer Center (US), University of Miami (US), Cornell University (US), Columbia University Irving Medical Center (US), Kettering University (US), NYU Langone Health (US), Presbyterian Hospital (US), New York University Langone Orthopedic Hospital (US), University of Colorado Anschutz Medical Campus (US), University of Colorado Denver (US)
Openalex Percentile: Top 17%
Histiocytic Disorders and Treatments
1.16
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.